Search Results - Hendrik Everaert
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
Interobserver ground-truth variability limits performance of automated glioblastoma segmentation on [18F]FET PET by Selene De Sutter, Ine Dirks, Laurens Raes, Wietse Geens, Hendrik Everaert, Sophie Bourgeois, Johnny Duerinck, Jef Vandemeulebroucke
Published in EJNMMI Physics (2025-06-01)Get full text
Article -
5
A Belgian single centre outcome study of radioiodine treatment in adolescents with Graves’ disease by Laura Chielens, Elise Nauwynck, Sophie Bourgeois, Willem Staels, Jesse Vanbesien, Inge Gies, Caroline Ernst, Hendrik Everaert, Jean De Schepper
Published in Scientific Reports (2024-12-01)Get full text
Article -
6
Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx) by Bart Neyns, Julia Katharina Schwarze, Gil Awada, Laila Ben Salama, Jennifer De Cremer, Lydia Fischbuch, Laura Seynaeve, Stephanie Du Four, Anne-Marie Vanbinst, Alex Michotte, Hendrik Everaert, Anne Rogiers, Peter Theuns, Johnny Duerinck
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article -
7
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial by Mark Kockx, Bart Neyns, Julia Katharina Schwarze, Gil Awada, Laura Seynaeve, Anne-Marie Vanbinst, Alex Michotte, Hendrik Everaert, Johnny Duerinck, Ramses Forsyth, Jens Tijtgat, Freya Vaeyens, Cleo Bertels, Wietse Geens, Samuel Klein, Louise Cras, Nicky D’Haene, Ben Caljon, Isabelle Salmon, Michaël Bruneau, Sonia Van Dooren
Published in Journal for ImmunoTherapy of Cancer (2021-06-01)Get full text
Article
